UCL Prostate Cancer Research Centre
- Seminars and Events
- Contact Us
- Support Us
- About Us
At the conference Room,
Prostate Cancer Research Centre,
Charles Bell House, 3rd Floor
We hold regular research talks and seminars on Tuesdays at 12.30 pm. Why not join us to share your thoughts with us.
We organise a wide range of fundraising events -
why not get involved!
Professor John Masters PhD FRCPath FRCR (Hon)
Professor of Experimental Pathology
Prostate Cancer Research Centre
Research Department of Urology
Charles Bell House
67-73 Riding House Street
Tel: 020 7679 9543
Urological Cancers, stem cells, human cell culture, cancer research
Editor in Chief for Cell Biology
Chairman of ATCC Standard Development on the Authentication of Human Cells
Scientific consultant for the Ovarian and Prostate Cancer Trust
Chief Executive of the Prostate Cancer Research Centre
Selected publications (since 2000)
American Type Culture Collection Standards Development Organisation Workgroup ASN0002. Cell line misidentification: the beginning of the end. Nature Reviews Cancer 10, 441-448, 2010
Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, Thrasivoulou C, Masters JRW, Ahmed A. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodelling and cell motility in prostate cancer. Plos One 5, e10456, 2010.
Young L, Sung J, Stacey G, Masters JR. Detection of Mycoplasma in cell cultures. Nature Protocols 5: 929-934, 2010.
Wells CM, Whale AD, Parsons M, Masters JRW, Jones GE. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci 123: 1663-1673, 2010.
Masters JRW, Palsson BO. Human Cell Culture Volume 7. Human adult stem cells. Springer, Dordrecht, 2009
Stacey N and Masters JRW. Cryopreservation and banking of mammalian cell lines. Nature Protocols 3: 1981-1989, 2008.
Masters JR, Kane C, Yamamoto H, Ahmed A. Prostate cancer stem cell therapy: hype or hope? Prostate Cancer and Prostatic Diseases, 11: 316-319, 2008
James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J, Popert RJ, Sanders K, Morgan RC, Stansfeld J, Dwyer J, Masters J, Parmar MKB. STAMPEDE: Systemic therapy for advancing or metastatic prostate cancer - a multi-arm multi-stage randomised controlled trial. Clinical Oncology 20: 577-581, 2008
Ahmed T, Shea K, Masters JRW, Jones GE, Wells CM. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Cell Signalling 20: 1320-1328, 2008.
Hastie C, Masters JR, Moss SE, Naaby-Hansen S. IFN-γ reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells. J Biol Chem 283: 12595-12603, 2008.
Masters JRW, Palsson BO and Thomson JA. Human Cell Culture Volume 6. Human embryonic stem cells. Springer, Dordrecht, 2007.
Wong OGW, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RSD, Bott SRJ, Nariculam J, Box G, Munson P, Constantinou J, Feneley M, Klocker H, Eccles SA, Negishi M, Freeman A, Masters JR, Williamson M. Plexin-B1 mutations in prostate cancer. Proc National Academy Sciences 104: 19040-19045, 2007.
Masters JR and Stacey GN. Changing medium and passaging cell lines. Nature Protocols 2, 2276-2284, 2007.
Wang Q, Williamson M, Bott S, Brookman-Amissah N, Freeman A, Nariculam J, Ahmed A, Masters JR. Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene, 26: 6560-6565, 2007.
Daly-Burns B, Alam TN, Mackay A, Clark J, Shepherd CJ, Rizzo S, Tatoud R, O'Hare MJ, Masters JR, Hudson DL. A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation. Differentiation 74: 1-14, 2006.
Hastie C, Saxton M, Akpan A, Cramer R, Masters JR and Naaby-Hansen S. Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells. Oncogene 24: 5905-5913, 2005.
Birtle AJ, Freeman A, Masters JRW, Payne HA, Harland SJ. Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10ng/mL. BJU Int 96: 303-307, 2005.
Nagano K, Masters JR, Akpan A, Yang A, Corless S, Wood C, Hastie C, Zvelebil M, Cramer R and Naaby-Hansen S. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons. Oncogene 23, 1693 - 1703, 2004.
Masters JR and Köberle B. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nature Cancer Reviews 3: 517-525, 2003.
Masters JRW, Vani UD, Grigor KM, Griffiths GO, Crook A, Parmar MKB, Knowles MA. Can p53 staining be used to identify patients with aggressive superficial bladder cancer? J Pathol 200: 74-81, 2003
Brown RSD, Edwards J, Dogan A, Payne H, Harland SJ, Bartlett JMS, Masters JRW. Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. J Pathol 198: 237-244, 2002.
Masters JRW. Hela cells 50 years on: the good, the bad and the ugly. Nature Reviews Cancer 2: 315-319, 2002.
Masters JRW. Methods to improve the efficacy of intravesical mitomycin C: results of a randomized phase III trial. Journal of the National Cancer Institute 93: 1574-1575, 2001.
Masters JRW, Thomson JA, Daly-Burns B, Reid YA, Dirks W, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KG, Debenham PG. STR profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 98: 8012-8017, 2001.
Masters JRW. Cancer cell lines. Nature Reviews Molecular Cell Biology 1: 233-236, 2000.
Hudson DL, O'Hare MJ, Watt FM and Masters JRW. Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest 80: 1243-1250, 2000.
Masters JRW and Lakhani SR. How microarrays can help cancer patients. Nature 404: 921, 2000.
Stacey GN, Masters JRW, Hay RJ, Drexler HG, MacLeod RAF, Freshney RI. Cell contamination leads to inaccurate data: we must take action now. Nature 403: 356, 2000.
Page last modified on 08 dec 11 17:04